MERLN Institute for Technology-Inspired Regenerative Medicine

What MERLN Institute for Technology-Inspired Regenerative Medicine does

MERLN Institute for Technology-Inspired Regenerative Medicine is a Maastricht, Netherlands-based research organization founded in 2014, employing 105 staff. Its name indicates a focus on regenerative medicine approached through technology-driven methods, consistent with an academic or quasi-academic research institute rather than a commercial product company.

No substantive operational detail is available from the input sources: the institute's own website returned only a verification/loading screen, and no product portfolio, customer list, pricing, partnerships, leadership roster, funding history, patents, or revenue figures were disclosed. This places MERLN in the category of an institution whose value lies in scientific output, talent, and intellectual capital rather than commercialized products or services.

The business model cannot be characterized from available evidence. Academic institutes of this size and profile are typically funded through a combination of host-university block funding, national research council grants (in the Netherlands, principally NWO/ZonMw), and competitive European framework program awards, but no such funding breakdown is provided. No commercial revenue model, pricing structure, or go-to-market motion is described. The headcount of 105 suggests a mid-sized research group, likely operating across multiple principal investigator-led labs, though the internal structure is not documented in the supplied data.

Name

MERLN Institute for Technology-Inspired Regenerative Medicine

Website

https://merlninstitute.com

Company type

Private

Headcount range

101–250 employees

Short description

MERLN Institute for Technology-Inspired Regenerative Medicine is a Maastricht, Netherlands-based research institute founded in 2014 with 105 employees, focused on technology-inspired regenerative medicine. It operates as an academic research organization, though no commercial products, customers, or funding sources are documented in the available data.

Ownership category

akta.pro rank

Product category

Regenerative Medicine Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAAAGAL

Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

SECONDARYHLAAAGAH

Cartilage, Bone & Musculoskeletal Regeneration

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

SECONDARYHLAAAGAG

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

SECONDARYHLAAAGAJ

Cardiovascular & Vascular Regeneration (vascular grafts, angiogenesis)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

• Regenerative medicine research
• Tissue engineering
• Biomaterials development
• Biofabrication technology
• Biomedical research

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Core offering

MERLN Institute for Technology-Inspired Regenerative Medicine is a research institute that conducts scientific research in regenerative medicine using technology-inspired approaches. The institute focuses on developing novel biomaterials, biofabrication techniques, and tissue engineering solutions for medical applications. It operates as an academic research organization producing research output and advancing regenerative medicine technologies.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Wake Forest Institute for Regenerative Medicine (WFIRM): University-affiliated regenerative medicine research institute focused on tissue engineering, cell therapy, and organ fabrication. Direct functional peer to MERLN, with comparable translational research scope and academic structure.
• Australian Regenerative Medicine Institute (ARMI, Monash): Monash University-affiliated regenerative medicine institute covering stem cells, tissue engineering, and developmental biology. Comparable scale and academic institute structure to MERLN.
• McGowan Institute for Regenerative Medicine: University of Pittsburgh-affiliated regenerative medicine institute covering biomaterials, tissue engineering, and clinical translation. Directly comparable in mandate, scale, and academic positioning to MERLN.
• Centre for Regenerative Medicine (University of Edinburgh): University of Edinburgh research centre conducting stem cell biology and regenerative medicine research with strong translational links. Direct peer in academic regenerative medicine scale and structure.
• Berlin Institute of Health Center for Regenerative Therapies (BCRT): Charité/BIH-affiliated translational regenerative medicine center in Berlin focused on cell therapies, biomaterials, and immune regeneration. Highly comparable in scope and European institutional model.

Emerging players

• BlueRock Therapeutics: Bayer-owned cell therapy company focused on pluripotent stem cell-derived regenerative therapies. Comparable in underlying regenerative medicine technology focus but operating as a commercial entity rather than an academic institute.

Broad incumbents

• Karolinska Institutet - Department of Cell and Molecular Biology: Karolinska Institute research department with substantial regenerative medicine activity, including cell, molecular, and translational research. A broader academic institution, but with directly overlapping regenerative medicine scope.
• Mesoblast Limited: Commercial regenerative medicine company developing cellular therapies for inflammatory and cardiovascular conditions. Operates in the same regenerative medicine therapeutic areas but as a publicly traded commercial entity, providing a benchmark for translational outcomes.
• Stanford Institute for Stem Cell Biology and Regenerative Medicine: Stanford University-affiliated research institute focused on stem cell and regenerative medicine. Larger and more resource-rich than MERLN but operates on a similar academic institute model with overlapping research areas.

Regional players

• Murdoch Children's Research Institute - Stem Cell Medicine: Major Australian pediatric research institute with a stem cell and regenerative medicine research theme. Comparable in academic-institute structure and translational research scope but based in a different geographic region.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/merln-institute-for-technology-inspired-regenerative-medicine

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MERLN Institute for Technology-Inspired Regenerative Medicine